Quality improvement in neurology

Epilepsy is a common, debilitating, and costly disease. It is estimated that 2.2 million people in the United States are diagnosed with epilepsy, and 150,000 new cases of epilepsy are diagnosed in the United States annually.1 However, epilepsy prevalence might be underestimated due to numerous social issues that accompany a diagnosis of epilepsy.2 People with epilepsy have poorer overall health status, impaired intellectual and physical functioning, and a greater risk for accidents and injuries.1–3 It is estimated that the annual direct medical cost of epilepsy in the United States is $9.6 billion, and this estimate does not include indirect costs from losses in quality of life or productivity.1

[1]  Suzanne B. Zane,et al.  Abortion surveillance--United States, 2005. , 2008, Morbidity and mortality weekly report. Surveillance summaries.

[2]  Catharyn T. Liverman,et al.  Epilepsy across the spectrum: Promoting health and understanding. A summary of the Institute of Medicine report , 2012, Epilepsy & Behavior.

[3]  W. Weiner,et al.  Quality improvement in neurology: AAN Parkinson disease quality measures , 2010, Neurology.

[4]  E. Beghi,et al.  Predictors of epilepsy surgery outcome: a meta-analysis , 2004, Epilepsy Research.

[5]  W. Tatum,et al.  Disobedience and driving in patients with epilepsy , 2012, Epilepsy & Behavior.

[6]  Steven C Schachter,et al.  Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005. , 2008, Morbidity and mortality weekly report. Surveillance summaries.

[7]  S Shinnar,et al.  How long does it take for partial epilepsy to become intractable? , 2003, Neurology.

[8]  W. Hauser,et al.  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency , 2009, Neurology.

[9]  Tracy Glauser,et al.  ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes , 2006, Epilepsia.

[10]  D. Thurman,et al.  Epilepsy in adults and access to care--United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[11]  Marco Mula,et al.  Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan , 2012, The Lancet.

[12]  L. Long,et al.  An Assessment of Epilepsy Patients' Knowledge of Their Disorder , 2000, Epilepsia.

[13]  M. Brodie,et al.  Diagnosing refractory epilepsy: response to sequential treatment schedules , 2006, European journal of neurology.

[14]  Vibhangini S. Wasade,et al.  AAN Epilepsy Quality Measures in clinical practice: A survey of neurologists , 2012, Epilepsy & Behavior.

[15]  M. Sperling,et al.  Health‐related quality of life over time since resective epilepsy surgery , 2007, Annals of neurology.

[16]  Amy E. Sanders,et al.  Quality Improvement in Neurology: Dementia Management Quality Measures , 2014, Journal of the American Geriatrics Society.

[17]  S. Duncan,et al.  Men with epilepsy—The lost tribe? Results of a nationwide survey of men with epilepsy living in the UK , 2007, Seizure.

[18]  D. Hesdorffer,et al.  Surveillance of epilepsy and prevention of epilepsy and its sequelae: lessons from the Institute of Medicine report. , 2013, Current opinion in neurology.

[19]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[20]  W. Weiner,et al.  Quality improvement in neurology: AAN epilepsy quality measures , 2010, Neurology.

[21]  D. Lindhout,et al.  Adults with a history of possible Dravet syndrome: An illustration of the importance of analysis of the SCN1A gene , 2011, Epilepsia.

[22]  S. Reich,et al.  Quality Improvement in Neurology: AAN Parkinson Disease Quality Measures , 2011, Neurology.

[23]  Patient assessment of physician performance of epilepsy quality-of-care measures , 2012, Neurology. Clinical practice.

[24]  Lippincott Williams Wilkins,et al.  Practice Parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[25]  Lisa M. Caylor,et al.  Managing epilepsy well: Self-management needs assessment , 2011, Epilepsy & Behavior.

[26]  D. Spencer,et al.  Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.

[27]  Adam B. Cohen,et al.  Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures , 2013, Neurology.

[28]  P. Curatolo,et al.  Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis , 2011, Epilepsy & Behavior.

[29]  Adam B. Cohen,et al.  Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.